Senti Biosciences is a synthetic biology company.

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

A biopharmaceutical company developing therapeutics to attack cancer stem cells.

Develops novel cell and gene therapies with pharmacologic operating systems.

A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases

A biotechnology company that develops treatments for cancer and hematologic conditions

A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.

Focused on transforming lives of patients with immune dysfunctions and cancer

DCPrime is a biotechnology company developing cancer immunotherapies.

Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.

Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.

Gadeta is a biotechnology company developing immunotherapies for treating cancer.

Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.

A company developing immune therapies for cancer and related diseases

XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.

A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells

Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.

Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.

Macomics is an Edinburgh-based immuno-oncology company.

Taiga Biotechnologies is a biotechnology company developing blood stem cell therapies for treating infectious diseases and cancer.

NewLink Genetics is a biopharmaceutical company focused on the discovery and development of immuno-oncology products.

A biotechnology company offering precision immunotherapy cancer treatments.

Unum Therapeutics is a biotechnology company developing cell therapy products for cancer immunotherapy applications.

Triumvira Immunologics is an adoptive Immunotherapy founded by Jonathan Bramson.

WindMIL Therapeutics is a biotechnology company developing cell therapy products for treating cancer.

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.

SpecificiT Pharma is a biotechnology company developing cancer immunotherapies using stem cells.

ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.

Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.

CatalYm is an innovative immunotherapies developer for cancer patients founded in 2016.

OncoImmunity is a personalized cancer immunotherapy using machine learning company founded in 2014 by Trevor Clancy, Richard Stratford and Trevor Clancy.

Antibody Therapies

Biotechnology firm focused on developing cancer treatments using activated dendritic cell immunotherapy.

Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.

OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.

Aivita Biomedical is a stem Cell Therapy founded in 2016.

Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next-generation immunotherapeutics.

F1 Oncology is a biotechnology company developing CAR-T therapies for the treatment of cancer.

Catamaran uses NK cells, synthetic biology, and non-viral cell engineering to create novel CAR-NK cell therapies.

Rakuten Medical is an antibody conjugates for cancer founded by Hiroshi Mikitani.

Oncolytic Immunotherapy

Leman Biotech is an AI-enabled metabolic cancer immunotherapy founded in 2021.

Affini-T Therapeutics, Inc is a TCR Cell Therapy.

Novasenta Inc. is a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies.

Monoclonal Antibodies

Vaximm is developing oral T-cell immunotherapies to treat cancer patients.